Improvements in genomic and molecular methods are expanding the range of potential
applications for circulating tumour DNA (ctDNA), both in a research setting and as a'liquid …

Background Cell‐free fetal DNA (cff DNA) non‐invasive prenatal testing (NIPT) is rapidly
expanding, and is being introduced at varying rates depending on country and condition …

Cell-free DNA (cfDNA) is easily accessible in peripheral blood and can be used as
biomarkers for cancer diagnostics, prognostics, and therapeutics. The applications of cfDNA …

High Risk Pregnancy examines the full range of challenges in general obstetrics, medical
complications of pregnancy, prenatal diagnosis, fetal disease, and management of labor …

Context Noninvasive prenatal determination of fetal sex using cell-free fetal DNA provides
an alternative to invasive techniques for some heritable disorders. In some countries this …

Highlights•Cell-free nucleic acids in body fluids contain tumour fragments that can be
profiled for prognostic and diagnostic information for the management of cancer.•cfDNA …

Over the past decade, advances in molecular biology and genomics techniques have
revolutionized the diagnosis and treatment of cancer. The technological advances in tissue …

Non-invasive prenatal diagnosis (NIPD) is based on fetal DNA analysis starting from a
simple peripheral blood sample, thus avoiding risks associated with conventional invasive …

Hill M, Finning K, Martin P, Hogg J, Meaney C, Norbury G, Daniels G, Chitty LS. Non‐
invasive prenatal determination of fetal sex: translating research into clinical practice. The …

The identification of cell-free fetal DNA (cffDNA) in maternal plasma in 1997 heralded the
most significant change in obstetric care for decades, with the advent of safer screening and …